Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 41 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9326950

    Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  2. US 9328142

    Lipopeptide inhibitors of RAS oncoproteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  3. US 9326992

    Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  4. US 9320786

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  5. US 9321834

    Anti-malarial compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  6. US 9320789

    Combinations of gene deletions for live attenuated shigella vaccine strains

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  7. US 9314448

    Method of inhibiting ABCG2 and other treatment methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  8. US 9314494

    Cranberry xyloglucan oligosaccharide composition

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  9. US 9316646

    Anti-human ROR1 antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  10. US 9314532

    Drug delivery vehicle

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  11. US 9309237

    HIV inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  12. US 9310368

    High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  13. US 9308163

    Methods of treating and preventing diseases and disorders of the central nervous system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  14. US 9303044

    7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  15. US 9296790

    Methods and compositions for protein delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  16. US 9290512

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  17. US 9283233

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted

  18. US 9278090

    Methods of preventing the development of mucositis and related disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  19. US 9277748

    Agonist/antagonist compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  20. US 9278089

    Method of treating HCV infection with a small molecule CHK2 inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  21. US 9272023

    Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  22. US 9273136

    Fully human anti-human NKG2D monoclonal antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  23. US 9273121

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  24. US 9273124

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.